Infection of host cells by Toxoplasma gondii is an active process, which is 25 regulated by secretion of microneme (MICs) and rhoptry proteins (ROPs and RONs) from 26 specialized organelles in the apical pole of the parasite. MIC1, MIC4 and MIC6 assemble 27 into an adhesin complex, secreted on the parasite surface and function to promote 28 infection competency. MIC1 and MIC4 are known to bind terminal sialic acid residues 29 and galactose residues, respectively and to induce IL-12 production from splenocytes. 30
4
IFN-g during acute toxoplasmosis can drive a lethal immune response, in which mice 89 succumb to infection by severe immunopathology, the result of insufficient levels of IL-90 10 and/or a collapse in the regulatory CD4+Foxp3+ T cell population [23, 24] . 91
Interestingly, regarding the innate immune receptors associated with IL-12 92 response during several infections, the extracellular leucine-rich repeat domains of 93 TLR2 and TLR4 contain four and nine N-glycans, respectively [25] . Therefore, we 94 hypothesized that MIC1 and MIC4 bind TLR2 and TLR4 N-glycans on antigen-95 presenting cells (APCs) and, through this interaction, trigger immune cell activation and 96 IL-12 production. To investigate this possibility, we assayed the ability of rMIC1 and 97 rMIC4 to bind and activate TLR2 and TLR4. Using several strategies, we demonstrated 98 that TLR2 and TLR4 are indeed critical targets for both MIC1 and MIC4. These 99 parasite and host cell structures establish lectin-carbohydrate interactions that contribute 100 to the induction of IL-12 production by innate immune cells, and we show here that the 101 The native MIC1/4 subcomplex purified from soluble T. gondii antigens has 108 lectin properties, so we investigated whether their recombinant counterparts retained the 109 sugar-binding specificity. The glycoarray analysis revealed the interactions of: i) the 110 Lac + subcomplex with glycans containing terminal α(2-3)-sialyl and β(1-4)-or β(1-3)-111 galactose; ii), rMIC1 with α(2-3)-sialyl residues linked to β-galactosides; and iii) of 112 rMIC4 with oligosaccharides with terminal β(1-4)-or β(1-3)-galactose ( Fig 1A) . The 113 combined specificities of the individual recombinant proteins correspond to the dual 114 sugar specificity of the Lac + fraction, demonstrating that the sugar-recognition 115 properties of the recombinant proteins are consistent with those of the native ones. 116
Based on the sugar recognition selectivity of rMIC1 and rMIC4, we tested two 117 oligosaccharides (α(2-3)-sialyllactose and lacto-N-biose) for their ability to inhibit the 118 interaction of the MICs with the glycoproteins fetuin and asialofetuin [26] . Sialyllactose 119 inhibited the binding of rMIC1 to fetuin, and lacto-N-biose inhibited the binding of 120 rMIC4 to asialofetuin ( Fig 1B) . To ratify the carbohydrate recognition activity of rMIC1 121 5 and rMIC4, we generated point mutations into the carbohydrate recognition domains 122 (CRDs) of the rMICs to abolish their lectin properties [11, 18, 27] . These mutated 123 forms, i.e. rMIC1-T126A/T220A and rMIC4-K469M, lost their capacity to bind to 124 fetuin and asialofetuin, respectively ( Fig 1B) , having absorbance as low as that in the 125 presence of the specific sugars. Thus, our results indicate that rMIC1 and rMIC4 126 maintained their lectin properties, and that the CRD function can be blocked either by 127 competition with specific sugars or by targeted mutations. 128 rMIC1 and rMIC4 trigger the activation of DCs and macrophages 129
We have previously demonstrated that the native Lac + subcomplex stimulates 130 murine adherent spleen cells to produce proinflammatory cytokines [20] . We evaluated 131 whether recombinant MIC1 and MIC4 retained this property and exerted it on BMDCs 132 and BMDMs. BMDCs (Fig 2A-2D ) and BMDMs (Fig 2E-2H ) produced high levels of 133 the proinflammatory cytokines IL-12 (Fig 2A and 2E ), TNF-α ( Fig 2B and 2F) , and IL-134 6 ( Fig 2C and 2G ). This was not attributable to residual LPS contamination as the 135 recombinant protein assays were done in the presence of polymyxin B, and LPS levels 136 were less than 0.5ng/ml [see Materials and Methods section]. Although conventional 137 CD4 + Th1 cells are known to be the major producers of IL-10 during murine T. gondii 138 infection [28], we also found that rMIC1 and rMIC4 induced the production of this 139 cytokine by BMDCs ( Fig 2D) and BMDMs ( Fig 2H) . We verified that the two 140 recombinant proteins induced the production of similar levels of IL-12, TNF-α, and IL-141 6 by both BMDCs (Fig 2A-2C) and BMDMs (Fig 2E-2G ). Both MICs induced the 142 production of similar levels of IL-10 in BMDCs ( Fig 2D) ; however, BMDMs produced 143 significantly higher levels of IL-10 when stimulated with rMIC1 than when stimulated 144 with rMIC4 ( Fig 2H) . These cytokine levels were similar to those induced by the TLR4 145 agonist LPS. Thus, recombinant MIC1 and MIC4 induce a proinflammatory response in 146 innate immune cells, which is consistent with the results obtained for the native Lac + 147 subcomplex [20] . 148
The activation of macrophages by rMIC1 and rMIC4 depends on TLR2 and TLR4 149
To investigate the mechanisms through which T. gondii MIC1 and MIC4 150 stimulate innate immune cells to produce cytokines, we assessed whether these MICs 151 can activate specific TLRs. To this end, BMDMs from WT, MyD88 -/-, TRIF -/-, TLR2 -/-, 152 TLR4 -/-, or TLR2/4 DKO mice, as well as HEK293T cells transfected with TLR2 or 153 TLR4, were cultured in the presence or absence of rMIC1 and rMIC4 for 48 hours. The 154 6 production of IL-12 by BMDMs ( Fig 3A-3I ) and IL-8 by HEK cells (Fig 3J and 3K ) 155 were used as an indicator of cell activation. IL-12 production by BMDMs from MyD88 -156 /-, TRIF -/-, TLR2 -/-, and TLR4 -/mice was lower than that of BMDMs from WT mice 157 (Fig 3A-3D); no IL-12 was detected in cultures of TLR2/4 DKO mice cells stimulated  158 with either rMIC1 or rMIC4 ( Fig 3E) . These results show that TLR2 and TLR4 are both 159 relevant for the activation of macrophages induced by rMIC1 and rMIC4. The residual 160 cytokine production observed in macrophages from TLR2 -/or MyD88 -/mice may be 161 the result of activation of TLR4 ( Fig 3A and 3C ), and vice versa; e.g., the residual IL-12 162 levels produced by macrophages from TLR4 -/mice may be the result of TLR2 163 activation. The finding that MICs fail to induce IL-12 production in DKO mice 164
BMDMs suggests that cell activation triggered by T. gondii MIC1 or MIC4 does not 165 require the participation of other innate immunity receptors beyond TLR2 and TLR4. 166
Nevertheless, because parasite components such as DNA or profilin engage TLR9, 167 TLR11, and TLR12 to produce IL-12 in macrophages [19, 22, 29] , we investigated the 168 involvement of these receptors, as well as TLR3 and TLR5, in the response to rMIC1 or 169 rMIC4. BMDMs from TLR3 -/-, TLR5 -/-, TLR9 -/-, and TLR11/12 DKO mice stimulated 170 with rMIC1 or rMIC4 produced similar levels of IL-12 as cells from WT ( Fig 3F-3I) , 171
indicating that the activation triggered by rMIC1 or rMIC4 does not depend on these 172 receptors. Additionally, stimulation of HEK cells transfected with human TLR2 ( Fig 3J) 173 or TLR4 ( Fig 3K) with optimal concentrations of rMIC1 (Fig S1A and S1C) and rMIC4 174 (Fig S1B and S1D) induced IL-8 production at levels that were higher than those 175 detected in the absence of stimuli (medium), and similar to those induced by the 176 positive controls. Finally, by means of a pull-down experiment, we demonstrated a 177 physical interaction between rMIC1 and TLR2 or TLR4 and between rMIC4 and TLR2 178 or TLR4 ( Fig 3L) . 179
Cell activation induced by rMIC1 and rMIC4 results from the interaction of their 180

CRDs with TLR2 and TLR4 N-glycans 181
We hypothesized that in order to trigger cell activation, rMIC1 and rMIC4 CRDs 182 target oligosaccharides of the ectodomains of TLR2 (four N-linked glycans) [25] and 183 TLR4 (nine N-linked glycans) [30] . This hypothesis was tested by stimulating BMDCs 184 ( Fig 4A) and BMDMs ( Fig 4B) from WT mice with intact rMIC1 and rMIC4 or with 185 the mutated forms of these microneme proteins, namely rMIC1-T126A/T220A and 186 rMIC4-K469M, which lack carbohydrate binding activity [11, 18, 27] . IL-12 levels in 7 culture supernatants were lower upon stimulation with rMIC1-T126A/T220A or rMIC4-188 K469M, showing that WT induction of cell activation requires intact rMIC1 and rMIC4 189 CRDs. The same microneme proteins were used to stimulate TLR2-transfected 190 HEK293T cells ( Fig 4C) , and similarly, lower IL-8 production was obtained in response 191 to mutated rMIC1 or rMIC4 compared to that seen in response to intact proteins. These 192 observations demonstrated that rMIC1 and rMIC4 CRDs are also necessary for inducing 193 HEK cell activation. 194
We used an additional strategy to examine the ability of rMIC1 and rMIC4 to 195 bind to TLR2 N-glycans. In this approach, HEK cells transfected with the fully N-196 glycosylated TLR2 ectodomain or with the TLR2 glycomutants [25] were stimulated 197 with a control agonist (FSL-1) or with rMIC1 or rMIC4. HEK cells transfected with any 198 TLR2 form, except those expressing totally unglycosylated TLR2 (mutant ∆1,2,3,4), 199
were able to respond to FSL-1 ( Fig 4D) , a finding that is consistent with the previous 200 report that the ∆1,2,3,4 mutant is not secreted by HEK293T cells [25] . Cells transfected 201 with TLR2 lacking only the first or the third N-glycan (mutant ∆1; ∆3) responded to all 202 stimuli. The response to the rMIC1 stimulus was significantly reduced in cells 203 transfected with five different TLR2 mutants, lacking some combination of the second, 204 third, and fourth N-glycans ( Fig 4D) . Moreover, rMIC4 stimulated IL-8 production was 205 significantly reduced in cells transfected with the mutants lacking some combination of 206 the third and fourth N-glycans ( Fig 4D) . 207
These results indicate that T. gondii MIC1 and MIC4 use their CRDs to induce 208 TLR2-and TLR4-mediated cell activation. Among the TLR2 N-glycans, the rMIC1 209 CRD likely targets the second, third, and fourth glycan, whereas the rMIC4 CRD targets 210 only the third and fourth. Additionally, our findings suggested that TLR2 and TLR4 211 activation is required to enhance the production of IL-12 by APCs following rMIC 212 stimulation. 213
The IL-12 production during T. gondii in vitro infection depends partially on MIC1 214 and MIC4 proteins and their ability to recognize carbohydrates on APCs surface. 215
Because IL-12 production is induced by rMICs that engage TLR2 and TLR4 N-216 glycans expressed on innate immune cells, we investigated whether such production is 217 impaired when APCs are infected with T. gondii lacking MIC1 and/or MIC4 proteins, 218 as well as complemented strains expressing mutant versions of these proteins that fail to 219 bind TLR2 or TLR4 carbohydrates. We generated Dmic1 and Dmic4 strains in an RH 220 9 Dmic4 and Dmic4::MIC4-K469M strains into the peritoneum of CD-1 outbred mice, a 254 lethal dose that causes acute mortality. The survival curve showed that parasites 255 deficient in MIC1 (Dmic1 group) or mutated to remove MIC1 lectin binding activity 256 (Dmic1::MIC1-T126A/T220A group) were less virulent, resulting in a slight, but 257 significant (p=0.0017) increase in mouse survival (12 days post-infection) compared to 258 WT infected mice that all succumbed to infection by day 10 ( Fig 6A) . This was not the 259 result of a difference in parasite load, which was equivalent across all T. gondii-infected 260 mice at Day 5 ( Fig 6D and 6I) . Whereas, the absence of the MIC4 gene or MIC4 lectin 261 activity did not change the survival curve ( Fig 6E) indicating that MIC4 is less relevant 262 than MIC1 during in vivo infection. 263
Acute mortality in CD-1 mice infected with Type I T. gondii is related to the 264 induction of a cytokine storm, mediated by high levels of IFN-g production. Thus, we 265 measured systemic levels of IFN-g and IL-12 in mice infected with WT, Dmic1, 266 
MIC1 wild type complemented strain restores the cytokine storm and acute 278 mortality kinetics during in vivo infection with T. gondii. 279
To formally show that MIC1 alters systemic levels of pro-inflammatory 280 cytokines associated with acute mortality, we complemented ∆mic1 parasites at the 281 endogenous locus with a Type I allele of MIC1 expressing an HA tag (MIC1 HA ). 282
Western blotting for either MIC1 or HA expression showed WT levels of MIC1 283 expression in the complemented parasites ∆mic1::MIC1 HA ( Fig 7A) . The complemented 284 strain restored WT virulence kinetics during in vivo infection and all mice died acutely, 285 in contrast to Dmic1 or Dmic1::MIC1-T126A/T220A parasites, that had a slight, but 286 10 significant delay in their acute mortality kinetics ( Fig 7B; p=0.0082). Systemic levels of 287 IFN-g ( Fig 7C) and parasite load ( Fig 7D and 7E ) from mice infected with the 288 complemented strain were indistinguishable from WT. To better resolve the apparent 289 difference in acute mortality, parasites were injected into the right footpad to monitor 290 mouse weight loss and survival kinetics [35] . Mice infected locally in the footpad with 291
Dmic1 survived significantly longer, or did not die ( Fig 7G; p=0 .0031), and lost less 292 weight during acute infection ( Fig 7F) than those infected with WT or Dmic1::MIC1 293 complemented parasites. Further, mice infected with Dmic1::MIC1-T126A/T220A 294 parasites that fail to bind TLR2 and TLR4 N-glycans in vivo also lost less weight and 295 survived significantly longer than WT or Dmic1::MIC1 complemented parasites ( Fig 7F  296 and G). In conclusion, our results suggest that MIC1 operates in two distinct ways; as an 297 adhesin protein that promotes parasite infection competency, and as a lectin that 298 engages TLR N-glycans to induce a stronger proinflammatory immune response, one 299 that is unregulated and results in acute mortality upon RH infection of CD-1 mice. 300 and attachment to, host cells [10]; however, MIC1 has been shown to play a role in 319 11 invasion and contributes to virulence in mice [10] . We previously isolated soluble 320 MIC1/4, a lactose-binding complex from soluble T. gondii antigens (STAg) [17] , and its 321 lectin activity was confirmed by the ability of MIC1 to bind sialic acid [9] and MIC4 to 322 β-galactose [18] . We also reported that MIC1/4 stimulates adherent splenic murine cells 323 to produce IL-12 at levels as high as those induced by STAg [20] . Recently, it was also 324 demonstrated that MIC1, MIC4 and MIC6 are capable of inducing IFN-g production 325 from memory T cells in mice chronically infected with T. gondii [37] . Our data herein 326 shows that MIC1/4 binds to and activates TLRs via a novel lectin-carbohydrate 327 interaction, rather than by its cognate receptor-ligand binding groove, establishing The binding of MIC1 and MIC4, as well as the lectins above, to TLR2 and 373 TLR4 may be associated with the position of the specific sugar residue present on the 374 receptor's N-glycan structure. Since the N-glycan structures of TLR2 and TLR4 are still 375 unknown, we assume that the targeted MIC1 and MIC4 residues, e.g. sialic acid α2-3-376 linked to galactose β1-3-and β1-4-galactosamines, are appropriately placed in the 377 receptors' oligosaccharides to allow the recognition phenomenon and trigger the 378 activation of innate immune responses. 379 Several T. gondii proteins have previously been shown to activate innate 380 immune cells in a TLR-dependent manner, but independent of sugar recognition. This is 381 the case for profilin (TgPRF), which is essential for the parasite's gliding motility based The carbohydrate-binding profile of microneme proteins was determined by 453 Core H (Consortium for Functional Glycomics, Emory University, Atlanta, GA), using 454 a printed glycan microarray, as described previously [56] . Briefly, rMIC1-Fc, rMIC4-455 Fc, and Lac + -Fc in binding buffer (1% BSA, 150 mM NaCl, 2 mM CaCl2, 2 mM MgCl2, 456 0.05% (w/v) Tween 20, and 20 mM Tris-HCl, pH 7.4) were applied onto a covalently 457 printed glycan array and incubated for 1 hour at 25 °C, followed by incubation with 458 Alexa Fluor 488-conjugate (Invitrogen, Thermo Fisher Scientific Inc., Grand Island, 459 NY). Slides were scanned, and the average signal intensity was calculated. The common 460 features of glycans with stronger binding are depicted in Fig. 1a . The average signal 461 intensity detected for all of the glycans was calculated and set as the baseline. 462
Sugar-inhibition assay 463
Ninety-six-well microplates were coated with 1 µg/well of fetuin or asialofetuin, 464 glycoproteins diluted in 50 µL of carbonate buffer (pH 9.6) per well, followed by 465 overnight incubation at 4 °C. Recombinant MIC1 or MIC4 proteins (both wild type 466 (WT) and mutated forms), previously incubated or not with their corresponding sugars, 467
i.e. α(2-3)-sialyllactose for MIC1 and lacto-N-biose for MIC4 (V-lab, Dextra, LA, UK), 468 were added into coated wells and incubated for 2 h at 25 °C. After washing with PBS, 469
T. gondii-infected mouse serum (1:50) was used as the source of the primary antibody. 470
The assay was then developed with anti-mouse peroxidase-conjugated secondary 471 antibody, and the absorbance was measured at 450 nm in a microplate-scanning 472 spectrophotometer (Power Wave-X; BioTek Instruments, Inc., Winooski, VT). 473
Mice and parasites 474
Female C57BL/6 (WT), MyD88 -/-, TRIF -/-, TLR2 -/-, TLR3 -/-, TLR4 -/-, double 10 µg/mL streptomycin (Gibco, Thermo Fisher Scientific Inc., Grand Island, NY). 504
Bone marrow-derived dendritic cells and macrophages 505
Bone marrows of WT, MyD88 -/-, TRIF -/-, TLR2 -/-, TLR3 -/-, TLR4 -/-, DKO 506 TLR2 -/-/TLR4 -/-, TLR5 -/-, TLR9 -/-, and DKO TLR11 -/-/TLR12 -/mice were harvested 507 from femurs and hind leg bones. Cells were washed with RPMI medium and 508 resuspended in RPMI medium with 10% FBS, 10 U/mL penicillin, and 10 µg/mL 509 streptomycin (Gibco). For dendritic cell (DC) differentiation, we added 10 ng/mL of 510 recombinant murine GM-CSF (Prepotech, Rocky Hill, NJ), and 10 ng/mL murine 511 recombinant IL-4 (eBioscience, San Diego, CA); for macrophage differentiation, 30% 512 of L929 conditioned medium was added to RPMI medium with 10% FBS. The cells 513
were cultured in 100 × 20 mm dish plates (Costar; Corning Inc., Corning, NY), 514 supplemented with respective conditioned media at days 3 and 6 for DCs, and at day 4 515 for macrophages. DCs were incubated for 8-9 days and macrophages for 7 days; the 516 cells were then harvested and plated into 24-well plates at 5 × 10 5 cells/well for protein 517 stimulations or T. gondii infections, followed by ELISA. Cell purity was analyzed by 518 flow cytometry. Eighty-five percent of differentiated dentritic cells were 519 CD11b + /CD11c + , while 94% of differentiated macrophages were CD11b + . 520
HEK293T cells transfection 521
Human embryonic kidney 293T (HEK293T) cells, originally acquired from 522 with the negative control for cell stimulation (the medium). Cells transfected with 535 empty vectors, incubated either with the medium or with agonists (FSL-1 or P3C), were 536 also assayed; negative results were required for each system included in the study. IL-8 537 was detected in the culture supernatants. The absence of Mycoplasma contamination in 538 the cell culture was certified by indirect fluorescence staining as described previously 539 [62] . 540
Cytokine measurement 541
The quantification of human IL-8 and mouse IL-12p40, IL-6, TNF-α, and IL-10 542 in the supernatant of the cultures was performed by ELISA, following the 543 manufacturer's instructions (OptEIA set; BD Biosciences, San Jose, CA). Human and 544 murine recombinant cytokines were used to generate standard curves and determine 545 cytokine concentrations. The absorbance was read at 450 nm using the Power Wave-X 546 spectrophotometer (BioTek Instruments). 547 
TLR2-FLAG and TLR4-FLAG plasmids
Pull-down assay and Western Blot 570
We used the lysate of HEK293T cells transfected (70-80% confluence) with 571 plasmids containing TLR2-FLAG or TLR4-FLAG. After 24 h of transfection, the HEK 572 cells were lysed with a non-denaturing lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 573 and 2 mM EDTA) supplemented with a protease inhibitor (Roche, Basel, Switzerland). 574
After 10 min of incubation on ice, the lysate was subjected to centrifugation (16,000 g, 575 at 4 °C for 5 min). The protein content in the supernatant was quantified by the BCA 576 method, aliquoted, and stored at -80 °C. For the pull-down assay, 100 µg of the lysate 577 from TLR2-FLAG-or TLR4-FLAG-transfected HEK cells were incubated with 10 µg 578 of TgMIC1 or TgMIC4 overnight at 4 °C. Since these proteins had a histidine tag, the 579 samples were purified on nickel-affinity resin (Ni Sepharose High Performance; GE 580 Healthcare, Little Chalfont, UK) after incubation for 30 min at 25 °C and centrifugation 581 of the fraction bound to nickel to pull down the TgMIC-His that physically interacted 582 with TLR-FLAG (16,000 g, 4 °C, 5 min). After washing with PBS, the samples were 583 resuspended in 100 μL of SDS loading dye with 5 μL of 2-mercaptoethanol, heated for 584 5 min at 95 ºC, and 25 μL of total volume was run on 10% SDS-PAGE. After 585 transferring to a nitrocellulose membrane (Millipore, Billerica, MA), immunoblotting 586 was performed by following the manufacturer's protocol. First, the membrane was 587 incubated with anti-FLAG monoclonal antibodies (1:2,000) (Clone G10, ab45766, 588
Sigma-Aldrich) to detect the presence of TLR2 or TLR4. The same membrane was then 589 subjected to secondary probing and was developed with anti-TgMIC1 (IgY; 1:20,000) 590 or anti-TgMIC4 (IgY; 1:8,000) polyclonal antibodies and followed by incubation with 591 secondary polyclonal anti-chicken IgY-HRP (1:4,000) (A9046, Sigma-Aldrich) to 592 confirm the presence of TgMIC1 and TgMIC4. 593
In vitro infections 594
Bone marrow-derived dendritic cells (BMDCs) and bone marrow-derived 595 macrophages (BMDMs) were infected with WT (Dku80/Dhpt), Dmic1, Dmic1::MIC1-596 T126A/T220A, Dmic4 or Dmic4::MIC4-K469M (Type I, RH background) strains 597 recovered from T25 flasks with HFF cell cultures. The T25 flasks were washed with 598 RPMI medium to completely remove parasites, and the collected material was 599 centrifuged for 5 min at 50 g to remove HFF cell debris. The resulting pellet was 600 discarded, and the supernatant containing the parasites was centrifuged for 10 min at 601 1,000 g and resuspended in RPMI medium for counting and concentration adjustments. 602
BMDCs and BMDMs were dispensed in 24-well plates at 5 × 10 5 cells/well (in RPMI 603 medium supplemented with 10% FBS), followed by infection with 3 parasites per cell 604 (multiplicity of infection, MOI 3). Then, the plate was centrifuged for 3 min at 200 g to 605 synchronize the contact between cells and parasites and incubated at 37 °C. The 606 supernatants were collected at 6, 12, 24, and 48 h after infection for quantification of 607 IL-12p40. 608
In vivo infections and Luciferase assay 609
Six-week-old female CD-1 outbred mice were infected by intraperitoneal 610 injection with 50 tachyzoites of RH engineered strains diluted in 500 µl of phosphate-611 buffered saline. The mice were weighed daily and survival was evaluated 612 20 Bioluminescent detection of firefly luciferase activity was performed at day 5 613 post-infection using an IVIS BLI system from Xenogen to monitor parasite burden. 614
Mice were injected with 3 milligrams (200 µl) of D-luciferin (PerkinElmer) substrate, 615 and after 5 minutes the mice were imaged for 300 seconds to detect the photons emitted. 616 617
Statistical analysis 618
The data were plotted and analysed using GraphPad Prism 7.0 software 619 (GraphPad, La Jolla, CA). Statistical significance of the obtained results was calculated 620 using analysis of variance (One-way ANOVA) followed by Bonferroni's multiple 621 comparisons test. Differences were considered significant when the P value was <0.05. 
